Drugs.com
MAY 27, 2024
MONDAY, May 27, 2024 -- If you're one of the millions of Americans walking around with a new knee or hip, your odds for an infection in that joint rise if you ever have to undergo cancer chemotherapy, researchers report.“Given the number of people o.
Drug Patent Watch
MAY 27, 2024
ACULAR LS (ketorolac tromethamine) Abbvie Patent: 9,216,167 Expiration: May 28, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.
Drugs.com
MAY 27, 2024
MONDAY, May 27, 2024 -- "Ugh, I'm so busy these days I can barely think straight. It's so crazy."No doubt some friend or coworker (maybe even yourself) has moaned about how stressed and overworked they are. Sometimes its fully justified, but in.
Reprocell
MAY 27, 2024
Rapid advancements in biomedical research have underscored the need for new drug discovery tools that offer a transformative pathway to expedite the identification and development of novel therapeutic interventions. Mesenchymal Stem Cells (MSCs; also known as Mesenchymal Stromal Cells) provide researchers with a crucial tool they need to revolutionize therapeutic development.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drugs.com
MAY 27, 2024
MONDAY, May 27, 2024 -- Does advising your teen sometimes feel like talking to the proverbial brick wall?Don't fret: New research shows that even when your preteen or teen gives your advice a flat "no way," your counsel is probably having an.
Drug Target Review
MAY 27, 2024
Caris Life Sciences® (Caris) has been at the forefront of precision medicine. How does the company see antibody-drug conjugates (ADCs) fitting into this approach? Antibody-drug conjugates have seen explosive growth in the last few years which has materialised with numerous clinical trials demonstrating meaningful improvements in survival. However, biopharma pipelines have been focused on optimising linkers and payloads around a relatively small number of cell-surface targets.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
FDA Law Blog: Biosimilars
MAY 27, 2024
Hyman, Phelps & McNamara, P.C. (HPM) proudly announces the return of Jennifer Newberger as a Director, further boosting its already robust medical device practice. Jennifer’s combination of experiences as in-house counsel for both large and start-up companies as well as outside counsel provides clients invaluable expertise and problem-solving skills.
Drug Patent Watch
MAY 27, 2024
Annual Drug Patent Expirations for ACULAR+LS Acular Ls is a drug marketed by Abbvie and is included in one NDA. It is available from three suppliers.
Perficient: Drug Development
MAY 27, 2024
Seamless integration between various systems and applications is crucial for efficient data sharing and enhanced functionality. Appian, a leading low-code automation platform, recognizes this need and provides a powerful toolset for creating Web APIs. Web APIs: Bridging the Gap Web APIs, or Application Programming Interfaces, serve as a bridge between different software applications, enabling them to communicate and share data seamlessly.
Drug Patent Watch
MAY 27, 2024
This chart shows the pharmaceutical companies with the most patents in Lithuania.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Crown Bioscience
MAY 27, 2024
Following our recent Teach me in Ten Talk, we’re looking at how organoid technology is changing the landscape of preclinical drug screening. These FAQs outline the advantages, scalability, and translatability of using organoids for drug screening, offering insights that bridge the gap between laboratory research and clinical application.
Expert insights. Personalized for you.
111 
Let's personalize your content